GeneDx Holdings (WGS) Share-based Compensation (2020 - 2026)
GeneDx Holdings (WGS) reported Share-based Compensation of $9.0 million for Q1 2026, up 125.86% year-over-year from $4.0 million in Q1 2025, and down 8.02% quarter-over-quarter from $9.8 million in Q4 2025.
GeneDx Holdings (WGS) Share-based Compensation (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has 7 years of Share-based Compensation data on file, last reported at $9.0 million in Q1 2026.
- Share-based Compensation for Q1 2026 came in at $9.0 million, up 125.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $37.2 million (up 173.91% YoY), and the FY2025 annual result was $32.2 million, up 251.96% from the prior year.
- Share-based Compensation retreated to $9.0 million in Q1 2026 per WGS's latest filing, from $9.8 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $22.7 million in Q2 2022 and troughed at -$912000.0 in Q4 2023.
- A 5-year average of $5.4 million and a median of $3.1 million in 2024 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2022 and 2024: Share-based Compensation soared 4477.84% in 2022, then sank 1039.58% in 2024.
- A 5-year view of Share-based Compensation shows it stood at $422000.0 in 2022, then plunged by 316.11% to -$912000.0 in 2023, then soared by 411.95% to $2.8 million in 2024, then soared by 243.76% to $9.8 million in 2025, then fell by 8.02% to $9.0 million in 2026.
- Business Quant data shows WGS's Share-based Compensation at $9.0 million in Q1 2026, $9.8 million in Q4 2025, and $10.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 20.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 83.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 58.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 16.34 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 32.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 95.11 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 65.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 60.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 5.47 Mn |
| 10 | GeneDx Holdings | 1.65 Bn | 1.48 Bn | 68.21 Mn | 9.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.00 Mn |
| Mar 31, 2026 | 9.00 Mn |
| Dec 31, 2025 | 9.78 Mn |
| Dec 31, 2025 | 9.78 Mn |
| Sep 30, 2025 | 10.59 Mn |
| Sep 30, 2025 | 10.59 Mn |
| Jun 30, 2025 | 7.81 Mn |
| Jun 30, 2025 | 7.81 Mn |
| Mar 31, 2025 | 3.98 Mn |
| Mar 31, 2025 | 3.98 Mn |
| Dec 31, 2024 | 2.85 Mn |
| Dec 31, 2024 | 2.85 Mn |
| Sep 30, 2024 | 3.64 Mn |
| Sep 30, 2024 | 3.64 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Mar 31, 2024 | -451,000.00 |
| Mar 31, 2024 | -451,000.00 |
| Dec 31, 2023 | -912,000.00 |
| Dec 31, 2023 | -912,000.00 |